Edwards Lifesciences boosts full-year profit outlook

February 2, 2016 9:31 PM

13 0

Edwards Lifesciences Corp (EW.N) raised its full-year earnings forecast on Tuesday, anticipating stronger sales of its artificial heart valves implanted in a minimally invasive procedure that spares patients from open-chest surgery.

Fourth-quarter net income rose to $140.7 million, or 64 cents a share, from $109.2 million, or 50 cents a share, a year ago. Sales increased 8.6 percent to $671.1 million.

Read more

To category page